These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16984065

  • 1. Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care.
    Jarbol DE, Bech M, Kragstrup J, Havelund T, Schaffalitzky de Muckadell OB.
    Int J Technol Assess Health Care; 2006; 22(3):362-71. PubMed ID: 16984065
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH, Warbasse L, Brenner C.
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [Abstract] [Full Text] [Related]

  • 3. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
    Jarbol DE, Kragstrup J, Stovring H, Havelund T, Schaffalitzky de Muckadell OB.
    Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
    Klok RM, Arents NL, de Vries R, Thijs JC, Brouwers JR, Kleibeuker JH, Postma MJ.
    Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting.
    Laheij RJ, Hermsen JT, Jansen JB, Horrevorts AM, Rongen RJ, Van Rossum LG, Witteman E, de Koning RW.
    Fam Pract; 2004 Jun; 21(3):238-43. PubMed ID: 15128682
    [Abstract] [Full Text] [Related]

  • 8. A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care.
    Barkun AN, Crott R, Fallone CA, Kennedy WA, Lachaine J, Levinton C, Armstrong D, Chiba N, Thomson A, Veldhuyzen van Zanten S, Sinclair P, Escobedo S, Chakraborty B, Smyth S, White R, Kalra H, Nevin K.
    Can J Gastroenterol; 2010 Aug; 24(8):489-98. PubMed ID: 20711528
    [Abstract] [Full Text] [Related]

  • 9. Initial management strategies for dyspepsia.
    Delaney BC, Moayyedi P, Forman D.
    Cochrane Database Syst Rev; 2003 Aug; (2):CD001961. PubMed ID: 12804417
    [Abstract] [Full Text] [Related]

  • 10. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group.
    Sonnenberg A, Schwartz JS, Cutler AF, Vakil N, Bloom BS.
    Arch Intern Med; 1998 Apr 27; 158(8):852-60. PubMed ID: 9570170
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis of two management strategies for dyspepsia.
    Kjeldsen HC, Bech M, Christensen B.
    Int J Technol Assess Health Care; 2007 Apr 27; 23(3):376-84. PubMed ID: 17579942
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
    Chiba N, Van Zanten SJ, Sinclair P, Ferguson RA, Escobedo S, Grace E.
    BMJ; 2002 Apr 27; 324(7344):1012-6. PubMed ID: 11976244
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
    Romano M, Marmo R, Cuomo A, De Simone T, Mucherino C, Iovene MR, Montella F, Tufano MA, Del Vecchio Blanco C, Nardone G.
    Clin Gastroenterol Hepatol; 2003 Jul 27; 1(4):273-8. PubMed ID: 15017668
    [Abstract] [Full Text] [Related]

  • 17. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
    Lane JA, Murray LJ, Noble S, Egger M, Harvey IM, Donovan JL, Nair P, Harvey RF.
    BMJ; 2006 Jan 28; 332(7535):199-204. PubMed ID: 16428249
    [Abstract] [Full Text] [Related]

  • 18. WITHDRAWN: Initial management strategies for dyspepsia.
    Delaney B, Ford AC, Forman D, Moayyedi P, Qume M.
    Cochrane Database Syst Rev; 2009 Oct 07; 2009(4):CD001961. PubMed ID: 19821286
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.